Myocardial Perfusion Imaging Using Positron Emission Tomography

Overview

Journal Methodist Debakey Cardiovasc J

Specialty Cardiology & Vascular Diseases

Date 2020 Jul 17

PMID 32670471

Citations 6

Authors

K Carlos El-Tallawi

Ahmed Aljizeeri

Faisal Nabi

Mouaz H Al-Mallah

Affiliations

Soon will be listed here.

Abstract

Coronary artery disease (CAD), also known as ischemic heart disease, is a major cause of morbidity and mortality worldwide, and timely noninvasive diagnosis of clinical and subclinical CAD is imperative to mitigate its burden on individual patients and populations. Positron emission tomography (PET) is a versatile tool that can perform relative myocardial perfusion imaging (MPI) with high accuracy; furthermore, it provides valuable information about the coronary microvasculature using rest and stress myocardial blood flow (MBF) and coronary flow reserve (CFR) measurements. Several radiotracers are approved by the US Food and Drug Administration to help with MPI, MBF, and CFR evaluation. A large body of evidence indicates that evaluation of the coronary microcirculation using MBF and CFR provides strong diagnostic and prognostic data in a multitude of patient populations. This review describes the technical aspects of PET compared to other modalities and discusses its clinical uses for diagnosis and prognosis of coronary arterial epicardial and microcirculatory disease.

Citing Articles

Evaluation of myocardial perfusion imaging techniques and artificial intelligence (AI) tools in coronary artery disease (CAD) diagnosis through multi-criteria decision-making method.

Erdagli H, Ozsahin D, Uzun B Cardiovasc Diagn Ther. 2025; 14(6):1134-1147.

PMID: 39790201 PMC: 11707470. DOI: 10.21037/cdt-24-237.

The role of cardiac PET in diagnosis and prognosis of patients with ischemia with no obstructive coronary arteries (INOCA).

Al-Mallah M, Nayfeh M, Alrifai M Am Heart J Plus. 2024; 43:100399.

PMID: 38828445 PMC: 11141139. DOI: 10.1016/j.ahjo.2024.100399.

Unveiling the Enigma: Exploring the Intricate Link Between Coronary Microvascular Dysfunction and Takotsubo Cardiomyopathy.

Datta P, Nath S, Pathade A, Yelne S Cureus. 2023; 15(9):e44552.

PMID: 37790001 PMC: 10544771. DOI: 10.7759/cureus.44552.

Integrative modeling of hemodynamic changes and perfusion impairment in coronary microvascular disease.

Colombo M, Chaudhry P, Oberholzer Y, deMello A Front Bioeng Biotechnol. 2023; 11:1204178.

PMID: 37564992 PMC: 10410158. DOI: 10.3389/fbioe.2023.1204178.

The Role of Cardiac PET in Diagnosis and Prognosis of Ischemic Heart Disease: Optimal Modality Across Different Patient Populations.

Nayfeh M, Ahmed A, Saad J, Alahdab F, Al-Mallah M Curr Atheroscler Rep. 2023; 25(7):351-357.

PMID: 37162723 PMC: 10170052. DOI: 10.1007/s11883-023-01107-0.

References

Berman D, Maddahi J, Tamarappoo B, Czernin J, Taillefer R, Udelson J . Phase II safety and clinical comparison with single-photon emission computed tomography myocardial perfusion imaging for detection of coronary artery disease: flurpiridaz F 18 positron emission tomography. J Am Coll Cardiol. 2012; 61(4):469-477. PMC: 4316725. DOI: 10.1016/j.jacc.2012.11.022. View

Murthy V, Bateman T, Beanlands R, Berman D, Borges-Neto S, Chareonthaitawee P . Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC. J Nucl Cardiol. 2017; 25(1):269-297. DOI: 10.1007/s12350-017-1110-x. View

WALSH M, Geltman E, Brown M, Henes C, Weinheimer C, Sobel B . Noninvasive estimation of regional myocardial oxygen consumption by positron emission tomography with carbon-11 acetate in patients with myocardial infarction. J Nucl Med. 1989; 30(11):1798-808. View

Taqueti V, Shaw L, Cook N, Murthy V, Shah N, Foster C . Excess Cardiovascular Risk in Women Relative to Men Referred for Coronary Angiography Is Associated With Severely Impaired Coronary Flow Reserve, Not Obstructive Disease. Circulation. 2016; 135(6):566-577. PMC: 5459611. DOI: 10.1161/CIRCULATIONAHA.116.023266. View

Marwick T, Case C, Sawada S, Rimmerman C, Brenneman P, Kovacs R . Prediction of mortality using dobutamine echocardiography. J Am Coll Cardiol. 2001; 37(3):754-60. DOI: 10.1016/s0735-1097(00)01191-8. View

Al-Mallah M, Aljizeeri A, Villines T, Srichai M, Alsaileek A . Cardiac computed tomography in current cardiology guidelines. J Cardiovasc Comput Tomogr. 2015; 9(6):514-23. DOI: 10.1016/j.jcct.2015.09.003. View

Dorbala S, Ananthasubramaniam K, Armstrong I, Chareonthaitawee P, DePuey E, Einstein A . Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging Guidelines: Instrumentation, Acquisition, Processing, and Interpretation. J Nucl Cardiol. 2018; 25(5):1784-1846. DOI: 10.1007/s12350-018-1283-y. View

Gould K, Johnson N . Coronary Physiology Beyond Coronary Flow Reserve in Microvascular Angina: JACC State-of-the-Art Review. J Am Coll Cardiol. 2018; 72(21):2642-2662. DOI: 10.1016/j.jacc.2018.07.106. View

Murthy V, Naya M, Foster C, Hainer J, Gaber M, Di Carli G . Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation. 2011; 124(20):2215-24. PMC: 3495106. DOI: 10.1161/CIRCULATIONAHA.111.050427. View

10.

Tonino P, De Bruyne B, Pijls N, Siebert U, Ikeno F, van t Veer M . Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009; 360(3):213-24. DOI: 10.1056/NEJMoa0807611. View

11.

Al Badarin F, Aljizeeri A, Almasoudi F, Al-Mallah M . Assessment of myocardial blood flow and coronary flow reserve with positron emission tomography in ischemic heart disease: current state and future directions. Heart Fail Rev. 2017; 22(4):441-453. DOI: 10.1007/s10741-017-9625-4. View

12.

Sampson U, Dorbala S, Limaye A, Kwong R, Di Carli M . Diagnostic accuracy of rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/computed tomography in the detection of coronary artery disease. J Am Coll Cardiol. 2007; 49(10):1052-8. DOI: 10.1016/j.jacc.2006.12.015. View

13.

Sanchis-Gomar F, Perez-Quilis C, Leischik R, Lucia A . Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med. 2016; 4(13):256. PMC: 4958723. DOI: 10.21037/atm.2016.06.33. View

14.

Naya M, Murthy V, Taqueti V, Foster C, Klein J, Garber M . Preserved coronary flow reserve effectively excludes high-risk coronary artery disease on angiography. J Nucl Med. 2014; 55(2):248-55. PMC: 3962818. DOI: 10.2967/jnumed.113.121442. View

15.

Dorbala S, Di Carli M, Beanlands R, Merhige M, Williams B, Veledar E . Prognostic value of stress myocardial perfusion positron emission tomography: results from a multicenter observational registry. J Am Coll Cardiol. 2012; 61(2):176-84. PMC: 3549438. DOI: 10.1016/j.jacc.2012.09.043. View

16.

Bergmann S, Herrero P, Markham J, Weinheimer C, WALSH M . Noninvasive quantitation of myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission tomography. J Am Coll Cardiol. 1989; 14(3):639-52. DOI: 10.1016/0735-1097(89)90105-8. View

17.

Dorbala S, Hachamovitch R, Curillova Z, Thomas D, Vangala D, Kwong R . Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF. JACC Cardiovasc Imaging. 2009; 2(7):846-54. PMC: 3954510. DOI: 10.1016/j.jcmg.2009.04.009. View

18.

Berman D, Kang X, Slomka P, Gerlach J, De Yang L, Hayes S . Underestimation of extent of ischemia by gated SPECT myocardial perfusion imaging in patients with left main coronary artery disease. J Nucl Cardiol. 2007; 14(4):521-8. DOI: 10.1016/j.nuclcard.2007.05.008. View

19.

Al-Mallah M, Sitek A, Moore S, Di Carli M, Dorbala S . Assessment of myocardial perfusion and function with PET and PET/CT. J Nucl Cardiol. 2010; 17(3):498-513. PMC: 2871404. DOI: 10.1007/s12350-010-9223-5. View

20.

Murthy V, Naya M, Taqueti V, Foster C, Gaber M, Hainer J . Effects of sex on coronary microvascular dysfunction and cardiac outcomes. Circulation. 2014; 129(24):2518-27. PMC: 4076200. DOI: 10.1161/CIRCULATIONAHA.113.008507. View